Drugs / peripheral blood stem cell graft that are CD34+ selected
peripheral blood stem cell graft that are CD34+ selected
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02165007 | Jan 2015 → Jan 2024 | sickle cell-beta-thalassemia disease syndrome, thalassemia | Catherine Bollard | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | peripheral blood stem cell graft that are CD34+ selected | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02165007 ↗ |